The main risk is not that the technology stops mattering; it is that value capture arrives later, narrower, or less durably than the stock implies. If
backlog slips, utilization lags, major customers push second sources, or licensing proves non-recurring, Vicor can still grow while failing to earn enough upside from today’s price.